메뉴 건너뛰기




Volumn 70, Issue , 2013, Pages 1-11

H1152 promotes the degradation of polyglutamine-expanded ataxin-3 or ataxin-7 independently of its ROCK-inhibiting effect and ameliorates mutant ataxin-3-induced neurodegeneration in the SCA3 transgenic mouse

Author keywords

H1152; Polyglutamine expanded ataxin 3; Polyglutamine expanded ataxin 7; Pontine nuclei; Rho kinase inhibitor; SCA3 transgenic mice

Indexed keywords

2 METHYL 1 [(4 METHYL 5 ISOQUINOLINE)SULFONYL]HOMOPIPERAZINE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 4 [4 (TRIFLUOROMETHYL)PHENYL] N (6 FLUORO 1H INDAZOL 5 YL) 2 METHYL 6 OXO 1,4,5,6 TETRAHYDRO 3 PYRIDINECARBOXAMIDE; ATAXIN 3; ATAXIN 7; GLUTAMINE; GSK 429286; H 1152; MUTANT PROTEIN; POLYGLUTAMINE; PROTEASOME; RHO KINASE; RHO KINASE 1; RHO KINASE 2; RHO KINASE INHIBITOR; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

EID: 84876987657     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.01.006     Document Type: Article
Times cited : (35)

References (30)
  • 1
    • 79959453367 scopus 로고    scopus 로고
    • Lopinavir up-regulates expression of the antiviral protein ribonuclease L in human papillomavirus-positive cervical carcinoma cells
    • G. Batman, A.W. Oliver, I. Zehbe, C. Richard, L. Hampson, and I.N. Hampson Lopinavir up-regulates expression of the antiviral protein ribonuclease L in human papillomavirus-positive cervical carcinoma cells Antivir. Ther. 16 2011 515 525
    • (2011) Antivir. Ther. , vol.16 , pp. 515-525
    • Batman, G.1    Oliver, A.W.2    Zehbe, I.3    Richard, C.4    Hampson, L.5    Hampson, I.N.6
  • 2
    • 69949170793 scopus 로고    scopus 로고
    • The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies
    • P.O. Bauer, and N. Nukina The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies J. Neurochem. 110 2009 1737 1765
    • (2009) J. Neurochem. , vol.110 , pp. 1737-1765
    • Bauer, P.O.1    Nukina, N.2
  • 4
    • 68049096318 scopus 로고    scopus 로고
    • The A2A adenosine receptor rescues the urea cycle deficiency of Huntington's disease by enhancing the activity of the ubiquitin-proteasome system
    • M.C. Chiang, H.M. Chen, H.L. Lai, H.W. Chen, S.Y. Chou, C.M. Chen, F.J. Tsai, and Y.J. Chern The A2A adenosine receptor rescues the urea cycle deficiency of Huntington's disease by enhancing the activity of the ubiquitin-proteasome system Hum. Mol. Genet. 18 2009 2929 2942
    • (2009) Hum. Mol. Genet. , vol.18 , pp. 2929-2942
    • Chiang, M.C.1    Chen, H.M.2    Lai, H.L.3    Chen, H.W.4    Chou, S.Y.5    Chen, C.M.6    Tsai, F.J.7    Chern, Y.J.8
  • 6
    • 45049085458 scopus 로고    scopus 로고
    • Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation
    • A.H. Chou, T.H. Yeh, P. Ouyang, Y.L. Chen, S.Y. Chen, and H.L. Wang Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation Neurobiol. Dis. 31 2008 89 101
    • (2008) Neurobiol. Dis. , vol.31 , pp. 89-101
    • Chou, A.H.1    Yeh, T.H.2    Ouyang, P.3    Chen, Y.L.4    Chen, S.Y.5    Wang, H.L.6
  • 7
    • 78651254160 scopus 로고    scopus 로고
    • P53 activation mediates polyglutamine-expanded ataxin-3 upregulation of Bax expression in cerebellar and pontine nuclei neurons
    • A.H. Chou, A.C. Lin, K.Y. Hong, S.H. Hu, Y.L. Chen, J.Y. Chen, and H.L. Wang p53 activation mediates polyglutamine-expanded ataxin-3 upregulation of Bax expression in cerebellar and pontine nuclei neurons Neurochem. Int. 58 2011 145 152
    • (2011) Neurochem. Int. , vol.58 , pp. 145-152
    • Chou, A.H.1    Lin, A.C.2    Hong, K.Y.3    Hu, S.H.4    Chen, Y.L.5    Chen, J.Y.6    Wang, H.L.7
  • 8
    • 78650613146 scopus 로고    scopus 로고
    • HDAC inhibitor sodium butyrate reverses transcriptional downregulation and ameliorates ataxic symptoms in a transgenic mouse model of SCA3
    • A.H. Chou, S.Y. Chen, T.H. Yeh, Y.H. Weng, and H.L. Wang HDAC inhibitor sodium butyrate reverses transcriptional downregulation and ameliorates ataxic symptoms in a transgenic mouse model of SCA3 Neurobiol. Dis. 41 2011 481 488
    • (2011) Neurobiol. Dis. , vol.41 , pp. 481-488
    • Chou, A.H.1    Chen, S.Y.2    Yeh, T.H.3    Weng, Y.H.4    Wang, H.L.5
  • 9
    • 84860660444 scopus 로고    scopus 로고
    • Toward understanding Machado-Joseph disease
    • M.C. Costa, and H.L. Paulson Toward understanding Machado-Joseph disease Prog. Neurobiol. 97 2012 239 257
    • (2012) Prog. Neurobiol. , vol.97 , pp. 239-257
    • Costa, M.C.1    Paulson, H.L.2
  • 10
    • 73249130297 scopus 로고    scopus 로고
    • Fasudil, a Rho kinase inhibitor, drives mobilization of adult neural stem cells after hypoxia/reoxygenation injury in mice
    • J. Ding, Q.Y. Li, J.Z. Yu, X. Wang, C.H. Sun, C.Z. Lu, and B.Z. Xiao Fasudil, a Rho kinase inhibitor, drives mobilization of adult neural stem cells after hypoxia/reoxygenation injury in mice Mol. Cell. Neurosci. 43 2010 201 208
    • (2010) Mol. Cell. Neurosci. , vol.43 , pp. 201-208
    • Ding, J.1    Li, Q.Y.2    Yu, J.Z.3    Wang, X.4    Sun, C.H.5    Lu, C.Z.6    Xiao, B.Z.7
  • 11
    • 33745088678 scopus 로고    scopus 로고
    • Molecular pathogenesis of spinocerebellar ataxias
    • A.M. Duenas, R. Goold, and P. Giunti Molecular pathogenesis of spinocerebellar ataxias Brain 129 2006 1357 1370
    • (2006) Brain , vol.129 , pp. 1357-1370
    • Duenas, A.M.1    Goold, R.2    Giunti, P.3
  • 12
    • 33750962224 scopus 로고    scopus 로고
    • Ataxin-3 represses transcription via chromati binding, interaction with histone deacetylase 3, and histone deacetylation
    • B.O. Evert, J. Araujo, A.M. Vieira-Saecker, R.A.I. de Vos, S. Harendza, T. Klockgether, and U. Wüllner Ataxin-3 represses transcription via chromati binding, interaction with histone deacetylase 3, and histone deacetylation J. Neurosci. 26 2006 11474 11486
    • (2006) J. Neurosci. , vol.26 , pp. 11474-11486
    • Evert, B.O.1    Araujo, J.2    Vieira-Saecker, A.M.3    De Vos, R.A.I.4    Harendza, S.5    Klockgether, T.6    Wüllner, U.7
  • 13
    • 65849122227 scopus 로고    scopus 로고
    • Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration
    • A.G. Garden, and A.R. La Spada Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration Cerebellum 22 2008 138 149
    • (2008) Cerebellum , vol.22 , pp. 138-149
    • Garden, A.G.1    La Spada, A.R.2
  • 17
    • 0344531010 scopus 로고    scopus 로고
    • Molecular analysis of Machado-Joseph disease
    • T. Kobayashi, and A. Kakizuka Molecular analysis of Machado-Joseph disease Cytogenet. Genome Res. 100 2003 261 275
    • (2003) Cytogenet. Genome Res. , vol.100 , pp. 261-275
    • Kobayashi, T.1    Kakizuka, A.2
  • 18
    • 77949775195 scopus 로고    scopus 로고
    • Repeat expansion disease: Progress and puzzles in disease pathogenesis
    • A.R. La Spada, and J.P. Taylor Repeat expansion disease: progress and puzzles in disease pathogenesis Nat. Rev. Genet. 11 2010 247 258
    • (2010) Nat. Rev. Genet. , vol.11 , pp. 247-258
    • La Spada, A.R.1    Taylor, J.P.2
  • 19
    • 0037160106 scopus 로고    scopus 로고
    • Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities
    • F. Li, T. Macfarlan, R.N. Pittman, and D. Chakravarti Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities J. Biol. Chem. 277 2002 45004 45012
    • (2002) J. Biol. Chem. , vol.277 , pp. 45004-45012
    • Li, F.1    MacFarlan, T.2    Pittman, R.N.3    Chakravarti, D.4
  • 20
    • 70350348368 scopus 로고    scopus 로고
    • Y-27632 improves rotarod performance and reduces huntingtin levels in R6/2 mice
    • M. Li, Y. Huang, A.A. Ma, E. Lin, and M.I. Diamond Y-27632 improves rotarod performance and reduces huntingtin levels in R6/2 mice Neurobiol. Dis. 36 2009 413 420
    • (2009) Neurobiol. Dis. , vol.36 , pp. 413-420
    • Li, M.1    Huang, Y.2    Ma, A.A.3    Lin, E.4    Diamond, M.I.5
  • 21
    • 79960668226 scopus 로고    scopus 로고
    • Polyglutamine diseases: The special case of ataxin-3 and Machado-Joseph disease
    • C.A. Matos, S. de Macedo-Ribeiro, and A.L. Carvalho Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease Prog. Neurobiol. 95 2011 26 48
    • (2011) Prog. Neurobiol. , vol.95 , pp. 26-48
    • Matos, C.A.1    De MacEdo-Ribeiro, S.2    Carvalho, A.L.3
  • 22
    • 18944372230 scopus 로고    scopus 로고
    • Rho kinase, a promising drug target for neurological diseases
    • B.K. Mueller, H. Mack, and N. Teusch Rho kinase, a promising drug target for neurological diseases Nat. Rev. Drug Discov. 4 2005 387 398
    • (2005) Nat. Rev. Drug Discov. , vol.4 , pp. 387-398
    • Mueller, B.K.1    MacK, H.2    Teusch, N.3
  • 23
    • 71749110782 scopus 로고    scopus 로고
    • The 26S proteasome: From basic mechanisms to drug targeting
    • A. Navon, and A. Ciechanover The 26S proteasome: from basic mechanisms to drug targeting J. Biol. Chem. 284 2009 33713 33718
    • (2009) J. Biol. Chem. , vol.284 , pp. 33713-33718
    • Navon, A.1    Ciechanover, A.2
  • 24
    • 34547692622 scopus 로고    scopus 로고
    • Trinucleotide repeat disorders
    • H.T. Orr, and H.Y. Zoghbi Trinucleotide repeat disorders Annu. Rev. Neurosci. 30 2007 576 621
    • (2007) Annu. Rev. Neurosci. , vol.30 , pp. 576-621
    • Orr, H.T.1    Zoghbi, H.Y.2
  • 25
    • 65849514220 scopus 로고    scopus 로고
    • SCA3: Neurological features, pathogenesis and animal models
    • O. Riess, U. Rüb, A. Pastore, P. Bauer, and L. Schöls SCA3: neurological features, pathogenesis and animal models Cerebellum 7 2008 125 137
    • (2008) Cerebellum , vol.7 , pp. 125-137
    • Riess, O.1    Rüb, U.2    Pastore, A.3    Bauer, P.4    Schöls, L.5
  • 26
    • 0035990918 scopus 로고    scopus 로고
    • The novel and specific Rho-kinase inhibitor (S)-(+)-2 -methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]homopiperazine as a probing molecule for Rho-kinase-involved pathway
    • Y. Sasaki, M. Suzuki, and H. Hidaka The novel and specific Rho-kinase inhibitor (S)-(+)-2 -methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]homopiperazine as a probing molecule for Rho-kinase-involved pathway Pharmacol. Ther. 93 2002 225 232
    • (2002) Pharmacol. Ther. , vol.93 , pp. 225-232
    • Sasaki, Y.1    Suzuki, M.2    Hidaka, H.3
  • 27
    • 71349088554 scopus 로고    scopus 로고
    • Amelioration of endothelial damage/dysfunction is a possible mechanism for the neuroprotective effects of Rho-kinase inhibitors against ischemic brain damage
    • S. Satoh, A. Hitomi, I. Ikegaki, K. Kawasaki, O. Nakazono, M. Iwasaki, M. Mohri, and T. Asano Amelioration of endothelial damage/dysfunction is a possible mechanism for the neuroprotective effects of Rho-kinase inhibitors against ischemic brain damage Brain Res. Bull. 81 2010 191 195
    • (2010) Brain Res. Bull. , vol.81 , pp. 191-195
    • Satoh, S.1    Hitomi, A.2    Ikegaki, I.3    Kawasaki, K.4    Nakazono, O.5    Iwasaki, M.6    Mohri, M.7    Asano, T.8
  • 28
    • 34249301303 scopus 로고    scopus 로고
    • Development of Rho-kinase inhibitors for cardiovascular medicine
    • H. Shimokawa, and M. Rashid Development of Rho-kinase inhibitors for cardiovascular medicine Trends Pharmacol. Sci. 28 2007 296 302
    • (2007) Trends Pharmacol. Sci. , vol.28 , pp. 296-302
    • Shimokawa, H.1    Rashid, M.2
  • 29
    • 33846220180 scopus 로고    scopus 로고
    • Polyglutamine-expanded ataxin-7 decreases nuclear translocation of NF-κB p65 and impairs NF-κB activity by inhibiting proteasome activity of cerebellar neurons
    • H.L. Wang, C.Y. He, A.H. Chou, T.H. Yeh, Y.L. Chen, and A.H. Li Polyglutamine-expanded ataxin-7 decreases nuclear translocation of NF-κB p65 and impairs NF-κB activity by inhibiting proteasome activity of cerebellar neurons Cell Signal. 19 2007 573 581
    • (2007) Cell Signal. , vol.19 , pp. 573-581
    • Wang, H.L.1    He, C.Y.2    Chou, A.H.3    Yeh, T.H.4    Chen, Y.L.5    Li, A.H.6
  • 30
    • 79952455313 scopus 로고    scopus 로고
    • Rho-associated coiled-coil-forming kinases (ROCKs): Potential targets for the treatment of atherosclerosis and vascular disease
    • Q. Zhou, C. Gensch, and J.K. Liao Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease Trends Pharmacol. Sci. 32 2011 167 173
    • (2011) Trends Pharmacol. Sci. , vol.32 , pp. 167-173
    • Zhou, Q.1    Gensch, C.2    Liao, J.K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.